Chelsey Bennett

Safety, pharmacokinetics and antiviral activity of PGT121, a broadly neutralizing monoclonal antibody against HIV-1: a randomized, placebo-controlled, phase 1 clinical trial

Kathryn E. Stephenson, Boris Jülg, Chen Sabrina Tan et al. · Nature Medicine · 2021 · 102 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study

Yehuda Z. Cohen, Allison L. Butler, Katrina G. Millard et al. · PLoS ONE · 2019 · 92 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Framework Mutations of the 10-1074 bnAb Increase Conformational Stability, Manufacturability, and Stability While Preserving Full Neutralization Activity

Bruce A. Kerwin, Chelsey Bennett, Yan Brodsky et al. · Journal of Pharmaceutical Sciences · 2019 · 19 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +17

Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector

Maryann Giel–Moloney, Mariano Estéban, Brendan Oakes et al. · Scientific Reports · 2019 · 11 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17